Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Anita Katharina Wagner, Dr.Pharm.

TitleAssociate Professor of Population Medicine
InstitutionHarvard Pilgrim Healthcare
DepartmentPopulation Medicine
AddressAmbulatory Care and Prevention
HMS/HPHC 6th Fl
133 Brookline Ave
Boston MA 02215
Phone617/509-9956
Fax617/859-8112

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AK. Health care payments in the asia pacific: validation of five survey measures of economic burden. Int J Equity Health. 2013; 12:49.
    View in: PubMed
  2. Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan D. Need for and access to health care and medicines: are there gender inequities? PLoS One. 2013; 8(3):e57228.
    View in: PubMed
  3. Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012; 2(6).
    View in: PubMed
  4. Zhang F, Wagner AK, Ross-Degnan D. Simulation-based power calculation for designing interrupted time series analyses of health policy interventions. J Clin Epidemiol. 2011 Nov; 64(11):1252-61.
    View in: PubMed
  5. Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat. 2011 Nov; 130(2):681-9.
    View in: PubMed
  6. Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan D. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy. 2011 May; 100(2-3):151-8.
    View in: PubMed
  7. Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SB. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy. Med Care. 2010 Jun; 48(6):503-9.
    View in: PubMed
  8. Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, Balikuddembe R, Chalker J, Wagner AK. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010; 10:42.
    View in: PubMed
  9. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2009 Feb; 62(2):143-8.
    View in: PubMed
  10. Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res. Published online 2008 October 31. doi: 10.1186/1472-6963-8-222. 2008.
  11. Vialle-Valentin C, Ross-Degnan D, Wagner AK. Medicine Coverage and Community-Based Health Insurance in Low-Income Countries. Health Res Policy Syst. Published online 2008 October 30. doi: 10.1186/1478-4505-6-11. 2008.
  12. Vialle-Valentin CE, Ross-Degnan D, Ntaganira J, Wagner AK. Medicines coverage and community-based health insurance in low-income countries. Health Res Policy Syst. 2008; 6:11.
    View in: PubMed
  13. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. Journal of Clinical Epidemiology. Epub ahead of print doi:10.1016/j.jclinepi.2008.08.007. 2008.
  14. Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. 2008; 8:161.
    View in: PubMed
  15. Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. Published online 2008 July 29. doi: 10.1186/1472-6963-8-161. 2008.
  16. Wagner AK, Soumerai SB, Graves AJ, Briesacher B, Zhang F, Gurwitz J, Ross-Degnan D. Catastrophic expenses and lack of access to health care and medications among middle-aged Americans (submitted). 2008.
  17. Wagner AK, Ross-Degnan D . The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries. Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific. K. Eggleston, Editor, under review. 2008.
  18. Briesacher BA, Ross-Degnan D, Adams AS, Wagner AK, Gurwitz J, Soumerai SB. Redefining the affordability of medication expenditures among Medicaid enrollees. J Health and Soc Policy Review (in press). 2008.
  19. Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. Epub ahead of print. doi:10.1016/j.healthpol.2008.07.001. 2008.
  20. Wagner AK, Ross-Degnan D, Gurwitz J, Soumerai SB. Benzodiazepines and hip fractures. Letter to the Editor. Ann Intern Med. 2007; 147(5):348.
  21. Wagner AK, Reiss S, Graves AJ, Ross-Degnan D. Results of feasibility study using World Health Survey data to measure medicines need, use, and out-of-pocket expenditures in eight low and lower-middle income countries. 2007.
  22. Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, Soumerai SB. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007 Jan 16; 146(2):96-103.
    View in: PubMed
  23. Wagner AK, Gandek B, Ware JE. SF-36 Health Survey: A Handbook for IQOLA Project Investigators. 2007.
  24. Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86.
    View in: PubMed
  25. Suttajit S, Tantipidoke R, Wagner AK, Ross-Degnan D, Sitthi-amorn C. Decisions about medication use by adults with respiratory infections in Bangkok slum communities: Implications for interventions to reduce antimicrobial resistance. Submitted. 2006.
  26. WHO Geneva, Department of Technical Cooperation on Essential Drugs and Traditional Medicines. Using Indicators to Measure Country Pharmaceutical Situations – Fact Book on WHO Level I and Level II Monitoring Indicators. World Health Organization: Geneva. 2006.
  27. Suttajit S, Wagner AK, Tantipidoke R, Ross-Degnan D, Sitthi-amorn C. Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok. Southeast Asian J Trop Med Public Health. 2005 Mar; 36(2):489-97.
    View in: PubMed
  28. Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005 Feb; 53(2):227-32.
    View in: PubMed
  29. Strassels SA, McNichol E, Wagner AK, Rogers WH, Gouveia WA, Carr DB. Persistent postoperative pain, health-realted quality of life, and functioning 1 month after hospital discharge. Acute Pain. 2004; 6(3-4):95-104.
  30. Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14):1567-72.
    View in: PubMed
  31. Proceedings of the Second International Conference on Improving the Use of Medicines. Available at http://mednet3.who.int/icium/icium2004/proceedings.asp. 2004.
  32. Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, Fanning T, Gallagher P, Ross-Degnan D. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care. 2003 Oct; 15(5):423-31.
    View in: PubMed
  33. Zhang F, Wagner AK, Soumerai S, Ross-Degnan D. Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. 2002; 748-754.
  34. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002 Aug; 27(4):299-309.
    View in: PubMed
  35. Wittink H, Hoskins Michel T, Wagner A, Sukiennik A, Rogers W. Deconditioning in patients with chronic low back pain: fact or fiction? Spine (Phila Pa 1976). 2000 Sep 1; 25(17):2221-8.
    View in: PubMed
  36. Wittink H, Michel TH, Kulich R, Wagner A, Sukiennik A, Maciewicz R, Rogers W. Aerobic fitness testing in patients with chronic low back pain: which test is best? Spine (Phila Pa 1976). 2000 Jul 1; 25(13):1704-10.
    View in: PubMed
  37. Rogers W, Wittink H, Wagner A, Cynn D, Carr D. Assessing individual outcomes during outpatients' multidisciplinary chronic pain therapy by means of an augmentes SF-36. Pain Med. 2000; 1(1):44-54.
  38. Dworetzky BA, Hoch DB, Wagner AK, Salmanson E, Shanahan CW, Bromfield EB. The impact of a single seizure on health status and health care utilization. Epilepsia. 2000 Feb; 41(2):170-6.
    View in: PubMed
  39. Wagner AK, Massaro FJ. Classification of donated drugs. An assessment of U.S. pharmaceutical donations: Players, processes, and products. Reich MR, ed. 1999.
  40. Wagner AK, Wyss K, Gandek B, Kilima PM, Lorenz S, Whiting D. A Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions. Qual Life Res. 1999; 8(1-2):101-10.
    View in: PubMed
  41. Wyss K, Wagner AK, Whiting D, Mtasiwa DM, Tanner M, Gandek B, Kilima PM. Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res. 1999; 8(1-2):111-20.
    View in: PubMed
  42. Reich MR, Wagner AK, McLaughlin TJ, Dumbaugh KA, Derai-Cochin M. Pharmaceutical donations by the USA: an assessment of relevance and time-to-expiry. Bull World Health Organ. 1999; 77(8):675-80.
    View in: PubMed
  43. Wagner AK, Gandek B, Aaronson NK, Acquadro C, Alonso J, Apolone G, Bullinger M, Bjorner J, Fukuhara S, Kaasa S, Leplège A, Sullivan M, Wood-Dauphinee S, Ware JE. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov; 51(11):925-32.
    View in: PubMed
  44. Wagner AK. The social determinants of health working group report. Robert Wood Johnson Foundation Investigator Awards in Health Policy Program. 1998.
  45. Wagner AK. A description by a care provider, contributed to: Schachter SC, Rowan AJ. The brainstorms healer. Epilepsy in our experience. Stories of health care professionals as care providers and patients. 1998.
  46. Wagner AK, Ehrenberg BL, Tran TA, Bungay KM, Cynn DJ, Rogers WH. Patient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care. Qual Life Res. 1997 May; 6(4):329-41.
    View in: PubMed
  47. Wagner AK. Using patient-based assessments for individual patient care. Pharmacoeconomics and outcomes: Applications for patient care. Bungay KM, Osterhaus JT, Paladino JA, Sanchez LA, eds. 1997; 363-416.
  48. Wagner AK, Shea CC, Sant G. Health-related quality of life issues. Interstitial Cystitis. Sant G, ed. 1997; 261-270.
  49. Wagner AK, Bungay KM, Kosinski M, Bromfield EB, Ehrenberg BL. The health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy. 1996 Jan-Feb; 16(1):1-9.
    View in: PubMed
  50. Bungay KM, Wagner AK. Introduction to pharmacist participation in measuring and monitoring patients' health-related quality of life. Am J Health Syst Pharm. 1995 Jul 15; 52(14 Suppl 3):S19-23.
    View in: PubMed
  51. Wagner AK, Bungay KM, Bromfield EB, Ehrenberg BL. Assessing the health status of adult patients with epilepsy. Am J Health Syst Pharm. 1995 Jul 15; 52(14 Suppl 3):S29-31.
    View in: PubMed
  52. Wagner AK, Vickrey BG. The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda. Qual Life Res. 1995 Apr; 4(2):169-77.
    View in: PubMed
  53. Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, Chadwick DW, Ware JE. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Qual Life Res. 1995 Apr; 4(2):115-34.
    View in: PubMed
  54. Bungay KM, Wagner AK. Comment: assessing the quality of pharmaceutical care. Ann Pharmacother. 1993 Dec; 27(12):1542-3.
    View in: PubMed
  55. Wagner AK. Assessing the health-related quality of life of people with epilepsy. International Epilepsy News. 1993; 27(114):12-14 (letter).
  56. Wagner AK. International Quality of Life Assessment (IQOLA)Project. Quality of Life Newsletter. 1992; 3:5.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Wagner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_